The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis (TB) and viral hepatitis, among people who inject drugs (PWID). The three-year project was launched in late 2015 with core funding by the Health Programme 2014-2020 from European Union (EU). Twenty-two partners representing 18 EU Member States were implementing the project. Additional expertise was provided by 14 collaborating partners, including the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The HA-REACT project has been carried out in three focus countries: Latvia, Lithuania and Hungary. However, materials developed as part of the Joint Action will be of benefit to the entire European Union.

In January 2019, the project has produced the following reports:

European Mapping of harm reduction interventions in prisons

Availability, Coverage and Barriers Towards Condom Provision in Prisons: A Review of the Evidence 

For more information about the HA-REACT, visit www.hareact.eu/en

Reply

Please Sign in (or Register) to view further.